BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6090358)

  • 21. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
    Milas L; McBride WH; Hunter N; Ito H
    Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.
    Smoluk GD; Fahey RC; Calabro-Jones PM; Aguilera JA; Ward JF
    Cancer Res; 1988 Jul; 48(13):3641-7. PubMed ID: 2837320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA; Connor AM; Grigsby P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327.
    Sigdestad CP; Grdina DJ; Connor AM; Hanson WR
    Radiat Res; 1986 May; 106(2):224-33. PubMed ID: 3010368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of some latent radioprotective compounds.
    Vos O; Budke L; Grant GA
    Int J Radiat Biol Relat Stud Phys Chem Med; 1976 Nov; 30(5):433-48. PubMed ID: 187547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioprotection by WR-2721 in vitro at low oxygen tensions: implications for its mechanisms of action.
    Durand RE
    Br J Cancer; 1983 Mar; 47(3):387-92. PubMed ID: 6299319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of mouse jejunal crypt cells by WR-2721 after small doses of radiation.
    Travis EL; Thames HD; Tucker SL; Watkins TL; Kiss I
    Int J Radiat Oncol Biol Phys; 1986 May; 12(5):807-14. PubMed ID: 3011713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation effects and radioprotection in MC3T3-E1 mouse calvarial osteoblastic cells.
    Gevorgyan A; Sukhu B; Alman BA; Bristow RG; Pang CY; Forrest CR
    Plast Reconstr Surg; 2008 Oct; 122(4):1025-1035. PubMed ID: 18827633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioprotection of the rat parotid gland by WR-2721 and isoproterenol and its modification by propranolol.
    Sodicoff M; Conger AD
    Radiat Res; 1983 Apr; 94(1):97-104. PubMed ID: 6304806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time dependence of interaction of misonidazole and WR-2721.
    Rojas A; Denekamp J
    Br J Radiol; 1983 Aug; 56(668):592-5. PubMed ID: 6307457
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration.
    Fatome M; Courteille F; Laval JD; Roman V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):21-9. PubMed ID: 3036725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the radioprotective effects of topical applications of MEA, WR-2721, and N-acetylcysteine on murine skin.
    Verhey LJ; Sedlacek R
    Radiat Res; 1983 Jan; 93(1):175-83. PubMed ID: 6296910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose and interval relationship for the interaction of WR-2721 and nitrogen mustard with normal and malignant cells.
    Valeriote F; Grates HE
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1561-4. PubMed ID: 6090362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioprotection of immunologically reactive T lymphocytes by WR-2721.
    Harris JW; Meneses JJ
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):437-40. PubMed ID: 211106
    [No Abstract]   [Full Text] [Related]  

  • 35. Protection of normal tissue against late radiation injury by WR-2721.
    Utley JF; Quinn CA; White FC; Seaver NA; Bloor CM
    Radiat Res; 1981 Feb; 85(2):408-15. PubMed ID: 6258191
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor sensitization and protection: influence of stromal injury on estimates of dose modification.
    Williams MV; Rojas A; Denekamp J
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1545-9. PubMed ID: 6090359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of stromal radiosensitivity by misonidazole and WR-2721.
    Begg AC; Terry NH
    Br J Radiol; 1983 Aug; 56(668):565-70. PubMed ID: 6307455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
    Steel LK; Jacobs AJ; Giambarresi LI; Jackson WE
    Radiat Res; 1987 Mar; 109(3):469-78. PubMed ID: 3031721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721.
    Calabro-Jones PM; Fahey RC; Smoluk GD; Ward JF
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jan; 47(1):23-7. PubMed ID: 2982751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.